These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31192906)

  • 1. Prognostic significance of blood inflammatory biomarkers NLR, PLR, and LMR in cancer-A protocol for systematic review and meta-analysis.
    Kumarasamy C; Sabarimurugan S; Madurantakam RM; Lakhotiya K; Samiappan S; Baxi S; Nachimuthu R; Gothandam KM; Jayaraj R
    Medicine (Baltimore); 2019 Jun; 98(24):e14834. PubMed ID: 31192906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic role of HE4 expression in multiple carcinomas: A protocol for systematic review and meta-analysis.
    Kumarasamy C; Madhav MR; Sabarimurugan S; Lakhotiya K; Pandey V; Priyadharshini T; Baxi S; Gothandam KM; Jayaraj R
    Medicine (Baltimore); 2019 Jul; 98(28):e15336. PubMed ID: 31305389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of microRNAs in head and neck cancers: a systematic review and meta-analysis protocol.
    Kumarasamy C; Devi A; Jayaraj R
    Syst Rev; 2018 Oct; 7(1):150. PubMed ID: 30285880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation scores as prognostic biomarkers in small cell lung cancer: a systematic review and meta-analysis.
    Winther-Larsen A; Aggerholm-Pedersen N; Sandfeld-Paulsen B
    Syst Rev; 2021 Jan; 10(1):40. PubMed ID: 33509254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Utility of Platelet-Lymphocyte Ratio, Neutrophil-Lymphocyte Ratio and Monocyte-Lymphocyte Ratio in Head and Neck Cancers: A Detailed PRISMA Compliant Systematic Review and Meta-Analysis.
    Kumarasamy C; Tiwary V; Sunil K; Suresh D; Shetty S; Muthukaliannan GK; Baxi S; Jayaraj R
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
    Shao Y; Li W; Wang D; Wu B
    World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic utility of preoperative inflammatory markers in patients with intrahepatic cholangiocarcinoma after hepatic resection: A systematic review and meta-analysis.
    Cui H; Li Y; Li S; Liu G
    Cancer Med; 2023 Jan; 12(1):99-110. PubMed ID: 35692190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of the neutrophil-to-lymphocyte ratio in the prognosis and risk of death for adult sepsis patients: a meta-analysis.
    Wu H; Cao T; Ji T; Luo Y; Huang J; Ma K
    Front Immunol; 2024; 15():1336456. PubMed ID: 38562922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.
    Leng J; Wu F; Zhang L
    Front Oncol; 2022; 12():734948. PubMed ID: 35651788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
    Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
    Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and predictive value of neutrophil-to-lymphocyte ratio after curative rectal cancer resection: A systematic review and meta-analysis.
    Hamid HKS; Davis GN; Trejo-Avila M; Igwe PO; Garcia-Marín A
    Surg Oncol; 2021 Jun; 37():101556. PubMed ID: 33819850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals.
    Guo W; Lu X; Liu Q; Zhang T; Li P; Qiao W; Deng M
    Cancer Med; 2019 Aug; 8(9):4135-4148. PubMed ID: 31197958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies.
    Yang Z; Gu JH; Guo CS; Li XH; Yang WC
    Oncotarget; 2017 Jul; 8(28):46414-46424. PubMed ID: 28423365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.
    Yu Y; Wang H; Yan A; Wang H; Li X; Liu J; Li W
    BMC Cancer; 2018 Apr; 18(1):383. PubMed ID: 29618336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiologic analysis of breast cancer incidence, prevalence, and mortality in India: Protocol for a systematic review and meta-analyses.
    Madhav MR; Nayagam SG; Biyani K; Pandey V; Kamal DG; Sabarimurugan S; Ramesh N; Gothandam KM; Jayaraj R
    Medicine (Baltimore); 2018 Dec; 97(52):e13680. PubMed ID: 30593138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Inflammatory Markers for Predicting Overall Survival in Patients with Osteosarcoma: A Systematic Review and Meta-Analysis.
    Song X; Zhang H; Yin F; Guo P; Yang X; Liu J; Han Y; Ren Z
    Mediators Inflamm; 2021; 2021():3456629. PubMed ID: 34720749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions.
    Page MJ; McKenzie JE; Kirkham J; Dwan K; Kramer S; Green S; Forbes A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):MR000035. PubMed ID: 25271098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of neutrophil-lymphocyte ratio (NLR) in patients with ovarian cancer: A systematic review and meta-analysis.
    Yin X; Wu L; Yang H; Yang H
    Medicine (Baltimore); 2019 Nov; 98(45):e17475. PubMed ID: 31702609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.